Coherus Biosciences | CHRS - Operating Expenses

Coherus Biosciences reported $96.84M in Operating Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
Acadia Pharmaceuticals ACAD:US USD 182.55M 20.97M
Akebia Therapeutics AKBA:US USD 61.53M 36.51M
ALKERMES ALKS:US USD 325.26M 12.26M
Alnylam Pharmaceuticals ALNY:US USD 523.65M 75.28M
Amarin AMRN:US USD 95.02M 62.25M
Amgen AMGN:US USD 4.61B 695M
Baxter International BAX:US USD 3.7B 2.88B
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Fujifilm 4901:JP JPY 662.5B 9.69B
Gilead Sciences GILD:US USD 5.12B 917M
Horizon Pharma HZNP:US USD 768.1M 3.34M
Ironwood Pharmaceuticals IRWD:US USD 38.84M 1.33M
JAZZ PHA JAZZ:US USD 1.24B 319.62M
Merk MRK:US USD 10.32B 624M
Myriad Genetics MYGN:US USD 230M 28.6M
Pacira Pharmaceuticals PCRX:US USD 181.85M 35.67M
Perrigo Ordinary Shares PRGO:US USD 1.12B 57.6M
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 367.75M 82.44M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Revance Therapeutics RVNC:US USD 194.33M 87.83M
Sarepta Therapeutics SRPT:US USD 367.84M 119.23M
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M
Xencor XNCR:US USD 64.3M 1.34M
Zoetis ZTS:US USD 1.45B 113M